RXL · ProShares Ultra Health Care ETF
ProShares Trust
$60.67
-2.17%
At close · Sep 4
Net assets $72,080,935
Holdings57
1 month
+6.50%
Year to date
+17.91%
52-week range
$39.32–$64.60
30-session avg volume
19,783
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000014253
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co. | LLY | $9,130,615 | 12.67% |
| Johnson & Johnson | JNJ | $5,662,318 | 7.86% |
| AbbVie, Inc. | ABBV | $4,013,668 | 5.57% |
| UnitedHealth Group, Inc. | UNH | $3,592,408 | 4.98% |
| Merck & Co., Inc. | MRK | $3,072,592 | 4.26% |
| Thermo Fisher Scientific, Inc. | TMO | $1,929,654 | 2.68% |
| Amgen, Inc. | AMGN | $1,891,413 | 2.62% |
| Gilead Sciences, Inc. | GILD | $1,739,121 | 2.41% |
| Intuitive Surgical, Inc. | ISRG | $1,572,867 | 2.18% |
| Pfizer, Inc. | PFE | $1,552,160 | 2.15% |
| Abbott Laboratories | ABT | $1,552,099 | 2.15% |
| Bristol-Myers Squibb Co. | BMY | $1,213,817 | 1.68% |
| CVS Health Corp. | CVS | $1,206,941 | 1.67% |
| Danaher Corp. | DHR | $1,198,315 | 1.66% |
| Vertex Pharmaceuticals, Inc. | VRTX | $1,185,533 | 1.64% |
| Stryker Corp. | SYK | $1,096,188 | 1.52% |
| McKesson Corp. | MCK | $948,096 | 1.32% |
| Elevance Health, Inc. | ELV | $904,730 | 1.26% |
| Cigna Group (The) | CI | $762,018 | 1.06% |
| Boston Scientific Corp. | BSX | $747,066 | 1.04% |
| Regeneron Pharmaceuticals, Inc. | REGN | $646,134 | 0.90% |
| HCA Healthcare, Inc. | HCA | $617,777 | 0.86% |
| Cencora, Inc. | COR | $546,531 | 0.76% |
| Edwards Lifesciences Corp. | EW | $523,316 | 0.73% |
| Cardinal Health, Inc. | CAH | $482,947 | 0.67% |
| IDEXX Laboratories, Inc. | IDXX | $469,420 | 0.65% |
| Becton Dickinson & Co. | BDX | $436,799 | 0.61% |
| Agilent Technologies, Inc. | A | $399,678 | 0.55% |
| Waters Corp. | WAT | $392,776 | 0.54% |
| Humana, Inc. | HUM | $384,218 | 0.53% |
| Zoetis, Inc. | ZTS | $341,991 | 0.47% |
| IQVIA Holdings, Inc. | IQV | $322,147 | 0.45% |
| Biogen, Inc. | BIIB | $299,880 | 0.42% |
| GE HealthCare Technologies, Inc. | GEHC | $296,240 | 0.41% |
| DexCom, Inc. | DXCM | $295,919 | 0.41% |
| Centene Corp. | CNC | $290,312 | 0.40% |
| ResMed, Inc. | RMD | $289,476 | 0.40% |
| Veeva Systems, Inc. | VEEV | $274,934 | 0.38% |
| Mettler-Toledo International, Inc. | MTD | $250,283 | 0.35% |
| West Pharmaceutical Services, Inc. | WST | $242,108 | 0.34% |
| Labcorp Holdings, Inc. | LH | $224,692 | 0.31% |
| Quest Diagnostics, Inc. | DGX | $223,550 | 0.31% |
| Viatris, Inc. | VTRS | $195,283 | 0.27% |
| Moderna, Inc. | MRNA | $170,969 | 0.24% |
| Zimmer Biomet Holdings, Inc. | ZBH | $170,176 | 0.24% |
| Incyte Corp. | INCY | $168,618 | 0.23% |
| Cooper Cos., Inc. (The) | COO | $125,113 | 0.17% |
| Revvity, Inc. | RVTY | $123,578 | 0.17% |
| Align Technology, Inc. | ALGN | $121,765 | 0.17% |
| Solventum Corp. | SOLV | $115,198 | 0.16% |